Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
145.66
-3.81 (-2.55%)
At close: May 15, 2026, 4:00 PM EDT
145.98
+0.32 (0.22%)
After-hours: May 15, 2026, 7:59 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $30.97 billion as of May 15, 2026. Its market cap has increased by 309.09% in one year.
Market Cap
30.97B
Enterprise Value
29.50B
1-Year Change
309.09%
Ranking
Category
Stock Price
$145.66
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $30.97B, an increase of 1,783.08%. That is a compound annual growth rate of 59.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 30.97B | 101.11% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 50.10B |
| Alnylam Pharmaceuticals | 38.32B |
| BeOne Medicines AG | 32.60B |
| Royalty Pharma | 30.43B |
| Insmed | 23.66B |
| BioNTech SE | 22.65B |
| Roivant Sciences | 20.96B |
| Moderna | 19.46B |